echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Nat Med: Immune response to two and three doses of BNT162b2 mRNA vaccine in adults with solid tumors

    Nat Med: Immune response to two and three doses of BNT162b2 mRNA vaccine in adults with solid tumors

    • Last Update: 2021-10-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have shown high efficacy, but participants with weakened immune systems have been excluded from controlled clinical trials


    immunity

    Recently, a research article was published in the top medical journal Nature Medicine.


    After the first vaccination, neutralizing antibodies were detected in 67% of cancer patients.


    Within one week after the third vaccination, the median neutralizing antibody response of the 16 participants increased three-fold, but no improvement in T cell response was observed, and adverse events were mild


    These results indicate that the third dose of BNT162b2 vaccination is safe, can improve humoral immunity against SARS-CoV-2, and may have immunological benefits for cancer patients receiving active chemotherapy


    The third dose of BNT162b2 vaccination is safe, can improve humoral immunity against SARS-CoV-2, and may have immunological benefits for cancer patients receiving active chemotherapy


    Original source:

    Rachna T.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.